香港大學

創新技術

Live-attenuated Influenza Vaccine with Alpha-1, 3-Galactosyltransferase Expression to Enhance Immune Response

(內容請參閱英文版)

The project develops a next-generation flu vaccine engineered to trigger a stronger immune response. By incorporating a natural sugar molecule (a-Gal), it effectively "flags" infected cells, directing the body's existing antibodies to rapidly eliminate them. This enhanced targeting mechanism results in broader and more robust protection against influenza, with significant potential to improve vaccine efficacy for global seasonal and pandemic preparedness.

 

Principal Investigator(s)

Team of the School of Public Health, LKS Faculty of Medicine:

 

Prof. Leo L.M. Poon
Professor, Chair of Public Health Virology

 

Email: impoon@hku.hk:

 

Dr. Alex W.H. Chin
Research Assistant Professor

 

Email: alexchin@hku.hk

Achievements and Awards

Special Grand Prize - Saudi Innovation Excellence Prize and Gold Medal with Congratulations of Jury, International Exhibition of Inventions Geneva 2025​

Learn More About This Technology Offering: